Skip to main content
. 2024 Apr 12;72:102595. doi: 10.1016/j.eclinm.2024.102595

Table 1.

Baseline characteristics of patients based on stroke severity and infarct core volume.

Variablea Lower NIHSS & smaller core (n = 139) Higher NIHSS & larger core (n = 106) Higher NIHSS & smaller core (n = 130) Lower NIHSS & larger core (n = 80) p valueb
Age, median (IQR), yr 66 (59–71) 69 (61–74) 70 (63–75) 67 (58–72) 0.01
Sex 0.01
 Male 89 (64.0) 53 (50.0) 78 (60.0) 59 (73.8)
 Female 50 (36.0) 53 (50.0) 52 (40.0) 21 (26.2)
Baseline NIHSS, median (IQR) 13 (11–14) 20 (17–22) 19 (17–21) 12 (10–14) <0.001
Medical history
 Hypertension 75 (54.0) 67 (63.2) 85 (65.4) 45 (56.3) 0.20
 Diabetes 19 (13.7) 27 (25.5) 24 (18.5) 13 (16.3) 0.12
 Hyperlipidemia 7 (5.0) 6 (5.7) 8 (6.2) 5 (6.3) 0.98
 Atrial fibrillation 25 (18.0) 28 (26.4) 36 (27.7) 15 (18.8) 0.16
 Stroke 23 (16.6) 13 (12.3) 24 (18.5) 13 (16.3) 0.63
 Current smoking 43 (30.9) 32 (30.2) 34 (26.2) 35 (43.8) 0.06
Systolic blood pressure, median (IQR), mmHg 147 (133–163) 154 (132–170) 151 (131–168) 148 (130–164) 0.55
Diastolic blood pressure, median (IQR), mmHg 85 (76–97) 87 (76–97) 85 (76–98) 83 (75–89) 0.26
Laboratory tests
 Blood glucose, median (IQR), mmol/L 6.9 (5.8–8.3) 7.8 (6.4–9.7) 7.0 (6.2–9.1) 7.0 (5.9–8.3) 0.05
 Creatinine, median (IQR), umol/L 65.0 (53.0–83.4) 69.0 (55.0–79.7) 70.2 (59.1–85.0) 67.0 (57.8–84.1) 0.44
ASPECTS based on CT, median (IQR) 4 (3–5) 3 (1–4) 3 (3–4) 3 (2–4) <0.001
 0 0 (0.0) 6 (5.7) 0 (0.0) 2 (2.5) <0.001
 1 1 (0.7) 21 (19.8) 1 (0.8) 10 (12.5)
 2 0 (0.0) 10 (9.4) 0 (0.0) 11 (13.8)
 3 63 (45.3) 41 (38.7) 68 (52.3) 26 (32.5)
 4 37 (26.6) 21 (19.8) 31 (23.9) 22 (27.5)
 5 38 (27.3) 7 (6.6) 30 (23.1) 9 (11.3)
Hemisphere affected <0.001
 Left 35 (25.2) 71 (67.0) 88 (67.7) 16 (20.0)
 Right 104 (74.8) 35 (33.0) 42 (32.3) 64 (80.0)
Occlusion site 0.02
 ICA 34 (24.5) 45 (42.5) 50 (38.5) 35 (43.8)
 MCA-M1 102 (73.4) 61 (57.6) 79 (60.8) 45 (56.3)
 MCA-M2 3 (2.2) 0 (0.0) 1 (0.8) 0 (0.0)
Stroke etiology 0.04
 Atherosclerosis 37 (26.6) 20 (18.9) 34 (26.2) 22 (27.5)
 Cardioembolic 55 (39.6) 56 (52.8) 69 (53.1) 29 (36.3)
 Others 47 (33.8) 30 (28.3) 27 (20.8) 29 (36.3)
Infarct core volume, median (IQR), mL 32 (11–55) 95 (79–118) 42 (17–56) 90 (78–120) <0.001
Critically hypoperfused (Tmax > 6s) volume, median (IQR), mL 162 (108–193) 199 (165–257) 158 (121–216) 208 (166–247) <0.001
Critically hypoperfused to infarct core ratio ≥1.8 and penumbra volume ≥15 mL 122 (91.7) 60 (61.9) 115 (91.3) 49 (70.0) <0.001
Intravenous thrombolysis 39 (28.1) 28 (26.4) 38 (29.2) 24 (30.0) 0.95
Wake-up stroke 47 (33.8) 31 (29.3) 48 (36.9) 21 (26.3) 0.36
Onset-to-door time, median (IQR), min 399 (209–707) 325 (199–630) 350 (190–559) 311 (163–575) 0.31
Onset-to-imaging time, median (IQR), min 466 (288–769) 373 (236–720) 410 (233–659) 366 (218–655) 0.17
Onset-to-randomization time, median (IQR), min 507 (337–803) 427 (283–760) 459 (293–708) 413 (259–698) 0.18
Onset-to-puncture time, median (IQR), min 616 (372–836) 454 (325–735) 428 (314–660) 464 (297–699) 0.13
Onset-to-reperfusion time, median (IQR), min 729 (431–956) 531 (392–797) 511 (409–704) 572 (408–852) 0.09
Treatment 0.41
 MM 69 (49.6) 50 (47.2) 60 (46.2) 46 (57.5)
 EVT 70 (50.4) 56 (52.8) 70 (53.9) 34 (42.5)
Successful reperfusion 25 (35.7) 18 (32.1) 30 (45.5) 12 (37.5) 0.47
Rescue therapy 16 (22.9) 6 (10.7) 8 (11.9) 4 (12.5) 0.19

NIHSS indicates National Institutes of Health Stroke Scale; IQR, interquartile range; ASPECTS, Alberta Stroke Program Early Compute Tomography Score; CT, Compute Tomography; ICA, internal carotid artery; MCA-M1, middle cerebral artery M1 segment; MCA-M2, middle cerebral artery M2 segment; MM, medical management; EVT, endovascular therapy.

a

Values are medians (interquartile range) or numbers (%).

b

p value < 0.0125 was considered of statistical significance.